Specialties

Trials find intensive control reduced cardiovascular events in high-risk, diagnosed patients.

Excessive weight gain due to intensive therapy can lead to increased cardiovascular risk factors.

Study shows that good periodontal health is necessary to achieve a favorable glycemic status.

Men and women with type 2 have different risk for obesity-related cancer when compared with general population.

Protecting the heart and helping to reduce mortality, study takes closer look at beta-adrenoceptor inhibition in diabetes.

It is unclear whether SGLT2i show reduction in mortality in all patients with type 2 or just in patients with type 2 diabetes with increased cardiovascular risk.

This is not one patient’s disaster averted but what I have experienced working in the field of diabetes and obesity for years. Many times patients who are taking glucose lowering and/or anti obesity medications will report different GI complaints-such as bloating, diarrhea, constipation, nausea, vomiting, and GERD. They tell me they are going to see a gastroenterologist for an evaluation.

Study confirms recent guideline changes on metformin use in moderate-to-severe chronic kidney disease.

Researchers complete examination of class of type 2 medication.

Very low incidence of end stage renal disease (ESRD) was found in patients with childhood-onset diabetes type 1 in Norway.